HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. grew its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 70,592 shares of the company’s stock after purchasing an additional 1,453 shares during the period. Oppenheimer Asset Management Inc. owned approximately 0.08% of HealthEquity worth $6,773,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of HQY. Louisiana State Employees Retirement System raised its stake in shares of HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund raised its stake in shares of HealthEquity by 0.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock valued at $1,706,000 after acquiring an additional 100 shares during the period. Raymond James Trust N.A. raised its stake in shares of HealthEquity by 4.8% in the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after acquiring an additional 132 shares during the period. CIBC Asset Management Inc grew its stake in shares of HealthEquity by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 2,640 shares of the company’s stock valued at $253,000 after buying an additional 139 shares in the last quarter. Finally, Sanctuary Advisors LLC grew its stake in shares of HealthEquity by 5.0% in the fourth quarter. Sanctuary Advisors LLC now owns 3,335 shares of the company’s stock valued at $320,000 after buying an additional 159 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on HQY shares. Barrington Research lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Wells Fargo & Company raised their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday. Raymond James raised their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday. Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Finally, JMP Securities raised their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $113.54.

HealthEquity Stock Performance

Shares of HQY stock opened at $109.76 on Friday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a fifty day moving average price of $104.84 and a 200 day moving average price of $93.08. The company has a market cap of $9.51 billion, a P/E ratio of 100.70, a PEG ratio of 1.60 and a beta of 0.55. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the firm posted $0.40 EPS. Sell-side analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock worth $3,895,788 over the last 90 days. 2.20% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.